Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Atopic dermatitis.

Bieber T.

Ann Dermatol. 2010 May;22(2):125-37. doi: 10.5021/ad.2010.22.2.125. Epub 2010 May 17.

2.

Interleukin-1 alpha blockade prevents hyperkeratosis in an in vitro model of lamellar ichthyosis.

O'Shaughnessy RF, Choudhary I, Harper JI.

Hum Mol Genet. 2010 Jul 1;19(13):2594-605. doi: 10.1093/hmg/ddq145. Epub 2010 Apr 12.

PMID:
20385541
3.

Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid.

Morizane S, Yamasaki K, Kabigting FD, Gallo RL.

J Invest Dermatol. 2010 May;130(5):1297-306. doi: 10.1038/jid.2009.435. Epub 2010 Jan 21.

4.

Functional roles of human kallikrein-related peptidases.

Sotiropoulou G, Pampalakis G, Diamandis EP.

J Biol Chem. 2009 Nov 27;284(48):32989-94. doi: 10.1074/jbc.R109.027946. Epub 2009 Oct 9. Review.

5.

Phosphorylation of protease-activated receptor-2 differentially regulates desensitization and internalization.

Ricks TK, Trejo J.

J Biol Chem. 2009 Dec 4;284(49):34444-57. doi: 10.1074/jbc.M109.048942. Epub 2009 Oct 8.

6.

The emerging roles of serine protease cascades in the epidermis.

Ovaere P, Lippens S, Vandenabeele P, Declercq W.

Trends Biochem Sci. 2009 Sep;34(9):453-63. doi: 10.1016/j.tibs.2009.08.001. Epub 2009 Aug 31. Review.

PMID:
19726197
7.

Role of the epidermal barrier in atopic dermatitis.

Proksch E, Fölster-Holst R, Bräutigam M, Sepehrmanesh M, Pfeiffer S, Jensen JM.

J Dtsch Dermatol Ges. 2009 Oct;7(10):899-910. doi: 10.1111/j.1610-0387.2009.07157.x. Epub 2009 Aug 14. Review. English, German.

PMID:
19682176
8.

Serine protease inhibitor lymphoepithelial Kazal type-related inhibitor tends to be decreased in atopic dermatitis.

Roedl D, Traidl-Hoffmann C, Ring J, Behrendt H, Braun-Falco M.

J Eur Acad Dermatol Venereol. 2009 Nov;23(11):1263-6. doi: 10.1111/j.1468-3083.2009.03302.x. Epub 2009 Jun 1.

PMID:
19522716
9.

Epidermal barrier dysfunction in atopic dermatitis.

Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ.

J Invest Dermatol. 2009 Aug;129(8):1892-908. doi: 10.1038/jid.2009.133. Epub 2009 Jun 4. Review.

10.

Increased stratum corneum serine protease activity in acute eczematous atopic skin.

Voegeli R, Rawlings AV, Breternitz M, Doppler S, Schreier T, Fluhr JW.

Br J Dermatol. 2009 Jul;161(1):70-7. doi: 10.1111/j.1365-2133.2009.09142.x. Epub 2009 Mar 30. Erratum in: Br J Dermatol. 2009 Aug;161(2):492.

PMID:
19416247
11.

Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome.

Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, Besson C, Dubus P, Hovnanian A.

J Exp Med. 2009 May 11;206(5):1135-47. doi: 10.1084/jem.20082242. Epub 2009 May 4.

12.

Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions.

Eissa A, Diamandis EP.

Biol Chem. 2008 Jun;389(6):669-80. doi: 10.1515/BC.2008.079. Review.

PMID:
18627299
13.

A methodology for performing global uncertainty and sensitivity analysis in systems biology.

Marino S, Hogue IB, Ray CJ, Kirschner DE.

J Theor Biol. 2008 Sep 7;254(1):178-96. doi: 10.1016/j.jtbi.2008.04.011. Epub 2008 Apr 20. Review.

14.

Positive feedback in cellular control systems.

Mitrophanov AY, Groisman EA.

Bioessays. 2008 Jun;30(6):542-55. doi: 10.1002/bies.20769. Review.

15.

The socioeconomic impact of atopic dermatitis in the United States: a systematic review.

Mancini AJ, Kaulback K, Chamlin SL.

Pediatr Dermatol. 2008 Jan-Feb;25(1):1-6. doi: 10.1111/j.1525-1470.2007.00572.x. Review.

PMID:
18304144
16.

Parameter sensitivity analysis of IL-6 signalling pathways.

Chu Y, Jayaraman A, Hahn J.

IET Syst Biol. 2007 Nov;1(6):342-52.

PMID:
18203580
17.

Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2.

Demerjian M, Hachem JP, Tschachler E, Denecker G, Declercq W, Vandenabeele P, Mauro T, Hupe M, Crumrine D, Roelandt T, Houben E, Elias PM, Feingold KR.

Am J Pathol. 2008 Jan;172(1):86-97. Epub 2007 Dec 21.

19.

Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.

Komatsu N, Saijoh K, Jayakumar A, Clayman GL, Tohyama M, Suga Y, Mizuno Y, Tsukamoto K, Taniuchi K, Takehara K, Diamandis EP.

J Invest Dermatol. 2008 May;128(5):1148-59. Epub 2007 Nov 8.

20.

Activation profiles and regulatory cascades of the human kallikrein-related peptidases.

Yoon H, Laxmikanthan G, Lee J, Blaber SI, Rodriguez A, Kogot JM, Scarisbrick IA, Blaber M.

J Biol Chem. 2007 Nov 2;282(44):31852-64. Epub 2007 Sep 6.

Supplemental Content

Support Center